Lite Strategy, Inc. Deferred Revenue
Lite Strategy, Inc. (LITS) had Deferred Revenue of $0 as of 2024-06-30, per its 10-K filed 2024-09-19.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenueCurrent · last filed 2024-09-19
- 2024-06-30: Deferred Revenue, Current $0.00.
- 2024-03-31: Deferred Revenue, Current $0.00.
- 2023-12-31: Deferred Revenue, Current $0.00.
- 2023-09-30: Deferred Revenue, Current $0.00.
| Period end | Deferred Revenue, Current | Deferred Revenue, Current as first filed |
|---|---|---|
| 2024-06-30 | $0.00 10-K · filed 2024-09-19 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $0.00 10-Q · filed 2024-02-13 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $317.00K 10-K · filed 2024-09-19 | |
| 2023-03-31 | $1.58M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $2.90M 10-Q · filed 2023-02-09 | |
| 2022-09-30 | $4.50M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $4.83M 10-K · filed 2023-09-26 | |
| 2022-03-31 | $4.79M 10-Q · filed 2022-05-23 | |
| 2021-12-31 | $5.67M 10-Q/A · filed 2022-05-23 | $13.52M 10-Q · filed 2022-02-10 |
| 2021-09-30 | $5.31M 10-Q/A · filed 2022-05-23 | $14.84M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $4.53M 10-K · filed 2022-09-08 | $14.61M 10-K · filed 2021-09-02 |
| 2021-03-31 | $19.14M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $4.25M 10-Q/A · filed 2022-05-23 | $19.48M 10-Q · filed 2021-02-04 |
| 2020-09-30 | $5.21M 10-Q/A · filed 2022-05-23 | $18.97M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $5.23M 10-K/A · filed 2022-05-23 | $14.78M 10-K · filed 2020-09-09 |
| 2020-03-31 | $2.48M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $3.06M 10-Q · filed 2020-02-06 | |
| 2019-09-30 | $3.67M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $4.96M 10-K · filed 2020-09-09 | |
| 2019-03-31 | $4.20M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $3.98M 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $740.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $788.00K 10-K · filed 2019-08-28 | |
| 2018-03-31 | $843.00K 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $890.00K 10-Q · filed 2018-02-08 | |
| 2017-09-30 | $947.00K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $996.00K 10-K · filed 2018-08-30 | |
| 2017-03-31 | $1.04M 10-Q · filed 2017-05-04 | |
| 2016-09-30 | $14.04M 10-Q · filed 2016-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |